Our intention is to provide a solution to help all patients suffering from bacterial biofilm infections by utilizing our cutting-edge technologies that will one day have the potential to enhance the current standard of care, with the goal being to allow patients to retain the implants. These technologies are currently under investigation for FDA marketing authorization.
1. Projected 2020 values. Source: Parisi T. What is the long term economic societal effect of periprosthetic infection after THA. Clin Orthop Relat Res. (2017) 475:1891-1900
2. Triantafyllopoulos GK, Poultsieds LA, Zhang W, Sculco PK, Ma Y, Sculco TP. Periprosthetic knee infections treated with irrigation and debridement: outcomes and preoperative predictive factors. J Arthroplasty. 2015;30:649-57.
3. Bradbury T, Fehring TK, Taunton M, Hanssen A, Azzam K, Parvizi J, Odum SM (2009) The fate o acute methicillinresistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. J Arthroplasty, 24(6 Suppl), 101-104.
4. Average age of 65, over a 5 year period. Source: Lum, Z. C., Natsuhara, K. M., Shelton, T.J., Giordani, M., Pereira, G. C., & Meehan, J. (Accepted/In press). Mortality During Total Knee Periprosthetic Joint Infection. Journal of Arthroplasty. https://doi.org/10.1016/j.arth. 2018.08.021
